| Nina Marie Willert, FNP-BC | |
|
4102 Pinion Dr, Usaf Academy, CO 80840-2502 | |
| (719) 333-5192 | |
| Not Available |
| Full Name | Nina Marie Willert |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 4102 Pinion Dr, Usaf Academy, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215205083 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1-132247 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nina Marie Willert, FNP-BC 4102 Pinion Dr, Usaf Academy, CO 80840-2502 Ph: (719) 333-5192 | Nina Marie Willert, FNP-BC 4102 Pinion Dr, Usaf Academy, CO 80840-2502 Ph: (719) 333-5192 |
News Archive
Exciting data from the 26th European Society of Thoracic Surgeons meeting shows an association between innovation, and improved patient outcomes and lowered hospital costs
With sales of electronic cigarettes, or "e-cigarettes," on the rise and expected to hit $1.5 billion this year, concerns over potential health risks of using the trendy devices are also gaining momentum and political clout. An article in Chemical & Engineering News, the weekly magazine of the American Chemical Society, delves into what scientists and regulators are doing about e-cigarettes, which are now being cleverly marketed under more appealing names such as hookah pens and vape pipes.
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.
Advisers to the two major presidential candidates during an online debate on the Wall Street Journal Web site discussed the effect that their health care proposals would have on the employer-sponsored health insurance market, the Journal's "Health Blog" reports.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its U.S. Patent Application Number 11/226,908 entitled "Methods for Treatment with Bucindolol Based on Genetic Targeting." The Notice of Allowance is the USPTO's official communication that the examination of the patent application has been successfully completed and that a patent will be issued.
› Verified 9 days ago
Dawn Michele Szarke, CPNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4102 Pinion Dr, 10th Medical Group, Usaf Academy, CO 80840 Phone: 719-333-5111 | |
Bethany Allison Casper, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4102 Pinion Dr, Usaf Academy, CO 80840 Phone: 719-684-5962 | |
Mrs. Janet Anne Kemp, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4102 Pinion Dr, Usaf Academy, CO 80840 Phone: 719-333-5181 | |
Mr. John Bryan Serrano, DNP, FNP-C,BSN, RNBC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4102 Pinion Drive, 10th Medical Group, Usaf Academy, CO 80840 Phone: 719-333-5180 | |
Dr. Tekia Lanelle Jones, PMHNP-BC, DNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5136 Community Center Dr, Usaf Academy, CO 80840 Phone: 719-333-5177 | |
Wendy Cole, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4102 Pinion Dr. 10 Mdg, Usaf Academy, CO 80840 Phone: 719-333-5177 |